Contact Us
  |  
  Search
Saturday, 21 July 2018
Program

I-20: A forum to discuss the important role that innovation will play in G20 nations achieving collective GDP growth of 1.8% by 2018

 

 

7.00am Arrival and accreditation
8.00am Auditorium comes to order
8.05am

Traditional ‘Welcome to Country’ – Songwoman Maroochy Barambah

8.10amWelcoming ceremony featuring Australian musician William Barton
8.20am  Welcome Message – The Hon. Tony Abbott MP, Prime Minister of Australia
8.25am Welcome Address – The Hon Bob Baldwin MP, Parliamentary Secretary to the Minister for Industry, officially representing the Hon Tony Abbott MP, Prime Minister of Australia
   
Theme 1- The Role of the Public Sector in Innovation: Stimulating Research and Fostering Entrepreneurialism
The cutting edge of economic growth is defined by the economy’s ability to innovate. Public policy and governance are important shapers of innovation performance. From direct funding of education and R&D to various regulatory frameworks, public policy and governance have a significant impact on innovation activities.
8.35am
 Plenary Speaker 1: James C Greenwood, President and CEO, BIO
8.55am  Panel 1 Moderator: David A. Miles AM, Former Chair, Innovation Australia 
  • Dr Stefan Hajkowicz, Leader CSIRO Futures
  • Raúl Rendón Montemayor, Director General for Innovation, Services and Internal Trade, Mexico
  • Dr. Abdulmuhesen bin Nasser Abanumy - Deputy Director, Innovation & Industrial Development Institute (IIDI), King Abdulaziz City for Science and Technology (KACST)
  • Assoc. Prof. Ilker Murat Ar, Head of Department, Ministry of Science, Industry and Technology, Republic of Turkey
9.55am
 Morning Tea
   
Theme 2 – Drivers of Innovation: Sustainability and the Bioeconomy 
The bioeconomy presents a unique opportunity to address complex global challenges while achieving economic growth. It has the potential to transform manufacturing, reduce waste, and promote sustainable production of renewable resources and their conversion into food, energy and bio-based products for a population forecast to grow to over 9 billion people by 2050.
10.25am
 Plenary Speaker 2: Jack A. Bobo, Senior Advisor for Biotechnology, United States Department of State
10.45am
 Panel 2  Moderator: Dr Susan Pond AM, Adjunct Professor in Sustainability, United States Studies Centre at the University of Sydney
  • Dr Shane Arnott, Director, Strategic Development and Experimentation, International Phantom Works, Boeing Defense, Space & Security
  • Dr Arvind Lali, Director, DBT-ICT Center for Energy and Biosciences, Institute of Chemical Technology
  • Jack A. Bobo, Senior Advisor for Biotechnology, United States Department of State  
  • Murray McLaughlin, Executive Director, Bioindustrial Innovations Canada
11.45am 
 Lunch
12.45pm
 Keynote address: ‘Überpreneurs – Creating Innovative Industries and Smarter Societies' by Professor Peter Andrews AO
   
Theme 3 - Innovation in Healthcare: R&D Breakthroughs and Challenges
The World Bank President Jim Young Kim, recently highlighted the importance of medical research and its role in responding to global health threats – with the recent outbreak of the Ebola virus as an exemplar,  “If you look at the investments into the National Institutes of Health in the United States and then look at what it led to in terms of jobs, economic growth, opportunity for scientists to then move their findings into industry and then really literally grow the economy it was one of the best investments we have ever made.”
1.15pm
 Plenary Speaker 3: Associate Professor Dimity Dornan AO, Executive Director and Founder of Hear and Say and Human-Bionics Interface Frontiers 
1.35pm
 Panel 3 Moderator: James C Greenwood, President and CEO, BIO
  • Associate Professor Dimity Dornan AO, Executive Director and Founder of Hear and Say and Human-Bionics Interface Frontiers 
  • Dr Babak Kateb, Founding Chairman of the Board of Society for Brain Mapping and Therapeutics; President, World Brain Mapping Foundation; Research Scientist, Department of Neurosurgery, Cedars-Sinai Medical Center
  • Jonathan Kua, Group Director, Industry Development, Singapore Agency for Science and Technology Research (A*STAR), and Director, Biomedical Sciences Industry Partnership Office
  • Professor Maree Smith, Executive Director, Centre for Integrated Preclinical Drug Development, The University of Queensland
  • Dr Jane Thomason, CEO, Abt JTA, AUSTRALIA
2.35pm
 Afternoon tea
   
Theme 4 - Innovation Investment Strategies and Access to Capital
Across every G20 country, a crucial factor that will determine the success of entrepreneurship is access to finance. Without the ability to secure funding, entrepreneurial companies will be unable to reach their growth potential and may not survive at all. One of the crucial requirements for an environment in which entrepreneurship can flourish is a financial system that supports entrepreneurs by expanding both traditional and innovative forms of lending.
3.05pm
 Plenary Speaker 4: Josh Lerner, Jacob H. Schiff Professor of Investment Banking, Harvard Business School, and head of the Entrepreneurial Management unit 
3.25pm
 Panel 4 Moderator: Josh Lerner, Jacob H. Schiff Professor of Investment Banking, Harvard Business School, and head of the Entrepreneurial Management unit
  • Yasser El-Ansary, Chief Executive, Australian Private Equity & Venture Capital Association Ltd
  • Oleg Preksin, B20 Sherpa and Vice President of the Russian Union of Industrialists and Entrepreneurs
  • Holly Ransom, Co-Chair Y20 Australia  
  • Mark Sowerby, Founder and Managing Director, Blue Sky Alternative Investments Limited
  • The Hon. Wayne Swan MP, Former Deputy Prime Minister and Treasurer of Australia 
4.25pm
 Closing remarks and handover to the Republic of Turkey 
4.35pm 
Thanks and presentation of gifts
5.00pm
 Cocktail reception 
6.30pm  Close of Summit